OncoCyte
Stock Forecast, Prediction & Price Target

OncoCyte Financial Estimates

OncoCyte Revenue Estimates

OncoCyte EBITDA Estimates

OncoCyte Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$7.72M
 
N/A
$958K
 
-87.60%
$1.50M
 
56.88%
Avg: $4.82M
Low: $4.82M
High: $4.82M
avg. 221.25%
Avg: $11.3M
Low: $11.3M
High: $11.3M
avg. 134.02%
Net Income
 
% change YoY
$-64.09M
 
N/A
$-73.44M
 
-14.57%
$-27.78M
 
62.17%
Avg: $-13.00M
Low: $-13.00M
High: $-13.00M
avg. 53.18%
Avg: $-10.86M
Low: $-10.86M
High: $-10.86M
avg. 16.47%
EBITDA
 
% change YoY
$-16.84M
 
N/A
$-30.39M
 
-80.46%
$-23.12M
 
23.93%
Avg: $-2.89M
Low: $-2.89M
High: $-2.89M
avg. 87.47%
Avg: $-6.78M
Low: $-6.78M
High: $-6.78M
avg. -134.02%
EPS
 
% change YoY
-$14.42
 
N/A
-$13.26
 
8.04%
-$3.75
 
71.71%
Avg: -$1.7
Low: -$1.7
High: -$1.7
avg. 54.66%
Avg: -$1.42
Low: -$1.42
High: -$1.42
avg. 16.47%
Operating Expenses
 
% change YoY
$47.13M
 
N/A
$30.31M
 
-35.68%
$25.63M
 
-15.42%
Avg: $55.82M
Low: $55.82M
High: $55.82M
avg. 117.73%
Avg: $130.63M
Low: $130.63M
High: $130.63M
avg. 134.02%

FAQ

What is OncoCyte stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 34.82% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is -13.00M, average is -13.00M and high is -13.00M.

What is OncoCyte stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 177.64% in 2025-2026.

We have gathered data from N/A analysts. Their low revenue estimate is $4.82M, average is $4.82M and high is $4.82M.

What is OncoCyte stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 35.56% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.7, average is -$1.7 and high is $-1.7.